Latest Articles

Publication Date
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer - CancerNetwork

Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer CancerNetwork

Published: Feb. 21, 2026, 2:18 p.m.
Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer - MSN

Comedian Fatiha El-Ghorri, 44, undergoes hysterectomy after being diagnosed with endometrial cancer MSN

Published: Feb. 21, 2026, 12:39 p.m.
JIPMER conducts Conference on Endometrial Cancers 2026 - PIB

JIPMER conducts Conference on Endometrial Cancers 2026 PIB

Published: Feb. 21, 2026, 10:05 a.m.
From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology.

Curcumin, a bioactive polyphenol derived from turmeric (Curcuma longa), has garnered substantial attention for its potent anti-inflammatory, antioxidant, and antineoplastic properties. This review explores the therapeutic potential of curcumin in …

Published: Feb. 20, 2026, midnight
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa

Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa

Published: Feb. 19, 2026, 12:54 a.m.
Brenner tumor associated with mucinous cyst and endometriosis: a case report.

Brenner tumors are rare ovarian neoplasms that often coexist with other epithelial tumors, most commonly mucinous cystic neoplasms. The association of Brenner tumors with endometriosis is unusual and not well-documented …

Published: Feb. 19, 2026, midnight
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria

Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria

Published: Feb. 18, 2026, 11:46 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com

Aprea reports second partial response in endometrial cancer trial Investing.com

Published: Feb. 18, 2026, 1:42 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal

Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally

Published: Feb. 18, 2026, noon
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!